5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.66▲ | 2.66▲ | 2.66▲ | 2.63▲ | 2.66▲ |
MA10 | 2.68▲ | 2.69▼ | 2.71▼ | 2.65▲ | 2.93▼ |
MA20 | 2.71▼ | 2.70▼ | 2.66▲ | 2.61▲ | 2.75▼ |
MA50 | 2.69▼ | 2.62▲ | 2.67▲ | 2.95▼ | 2.33▲ |
MA100 | 2.63▲ | 2.66▲ | 2.59▲ | 2.66▲ | 2.88▼ |
MA200 | 2.69▼ | 2.62▲ | 2.77▼ | 2.45▲ | 9.21▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.009▼ | -0.010▼ | -0.004▼ | 0.030▲ | -0.056▼ |
RSI | 47.623▼ | 51.625▲ | 52.986▲ | 48.783▼ | 49.841▼ |
STOCH | 12.650▼ | 13.730▼ | 30.021 | 46.152 | 26.300 |
WILL %R | -63.333 | -68.571 | -63.158 | -40.776 | -73.453 |
CCI | -24.561 | -53.860 | -24.970 | 65.263 | -65.324 |
Monday, August 25, 2025 08:30 AM
Austin, Texas, United States, August 25th, 2025, FinanceWire NRx Pharmaceuticals has filed a Citizen Petition with the FDA to remove benzethonium ...
|
Monday, May 12, 2025 05:04 AM
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report First Quarter 2025 Financial Results on May 15, 2025 Published May 12, 2025 8:03am EDT ...
|
Wednesday, April 30, 2025 05:46 AM
MIAMI, April 30, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc., (Nasdaq:NRXP or "the Company"), today announced the grant of a filing fee waiver by the US Food and Drug Administration ("FDA") to ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/08/25 | 2.78 | 2.78 | 2.63 | 2.685 | 198,425 |
25/08/25 | 2.68 | 2.8197 | 2.66 | 2.69 | 542,592 |
22/08/25 | 2.59 | 2.69 | 2.54 | 2.64 | 702,381 |
21/08/25 | 2.60 | 2.67 | 2.53 | 2.53 | 239,465 |
20/08/25 | 2.50 | 2.645 | 2.40 | 2.62 | 263,513 |
19/08/25 | 2.83 | 2.83 | 2.4817 | 2.505 | 464,682 |
18/08/25 | 2.86 | 2.86 | 2.60 | 2.76 | 904,943 |
15/08/25 | 2.76 | 2.95 | 2.6001 | 2.89 | 570,761 |
14/08/25 | 2.65 | 2.79 | 2.64 | 2.67 | 642,457 |
13/08/25 | 2.41 | 2.55 | 2.35 | 2.53 | 326,348 |
|
|
||||
|
|
||||
|
|